Abstract
It is believed that the future of medicine lies in nanotechnology where the medicines would be tailor-made according to the requirement of the individual. With the amassed recognition of the potential of nanomaterials they are not only used in medicines but in many other consumer products. Nanomaterials exists in nature everywhere and many others are engineered. Because of the omnipresence of these nanoparticles human beings are blatantly exposed to them. Nevertheless, our knowledge about health and environmental risks of these engineered nanomaterials still remains limited and largely incomplete. Many studies confer their toxicity in animal models where they can lead to teratogenicity, genotoxicity and also defects in organs like liver, lungs , kidneys and immune system. However, the toxic responses depends upon many variables including size, shape, charge , composition and surface area. Nanoparticles (NPs) of same compositions can diverge in term of toxicity by changing the size, shape and charge of NPs. Likewise the time of exposure also plays very vita role in toxicity. Many available studies provide incomplete information by conducting few in vitro analyses. However, the process is so intricate that the in vitro studies are not sufficient to provide enough information to elucidate the full toxic potential. Therefore, in vivo studies are pre-requisite. This chapter provides an insight from toxicologist`s perspective on the matter, outlining possible routes of uptake by humans, known or suspected toxic effects, and the possible practical implication for human health risk assessment and public perception.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- NP:
-
Nano-particles
- UFP:
-
Ultra Fine Particles
- QSAR:
-
Quantitative Structure Activity Relationship
- LDH:
-
Lactate Dehydrogenase
- nm:
-
Nanometer
- TiO2:
-
Titanium Oxide
- TNF:
-
Tumor Necrosis Factor
- SiO2:
-
Silicon Dioxide
- Ni NPs:
-
Nickel Nano-particles
- Co NPs:
-
Cobalt Nano-particles
- IL:
-
Interleukin
- Au:
-
Gold
- Ag:
-
Silver
- Si NPs:
-
Silicon Nano-particles
- PBS:
-
Phosphate-buffered Saline
- BBB:
-
Blood Brain Barrier
- CNS:
-
Central Nervous System
- FDA:
-
Food and Drug Administration
References
Ahmad J, Ahamed M, Akhtar MJ, Alrokayan SA, Siddiqui MA, Musarrat J, Al-Khedhairy AA (2012) Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2. Toxicol Appl Pharmacol 259:160–168
Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML (2009) nanomaterials physiochemical properties on in vivo toxicity. Adv Drug Deliv Rev 61:457–466
Alkilany AM, Frey RL, Ferry JL, Murphy CJ (2008) Gold nanorods as nanoadmicelles: 1-naphthol partitioning into a nanorod-bound surfactant bilayer. Langmuir 24:10235–10239
Allegri M, Bianchi MG, Chiu M, Varet J, Costa AL, Ortelli S, Blosi M, Bussolati O, Poland CA, Bergamaschi E (2016) Shape-related toxicity of titanium dioxide nanofibres. PLoS ONE 11:e0151365
Anderson DS, Silva RM, Lee D, Edwards PC, Sharmah A, Guo T, Pinkerton KE, Van Winkle LS (2015) Persistence of silver nanoparticles in the rat lung: Influence of dose, size, and chemical composition. Nanotoxicology 9:591–602
Andersson POLC, Ekstrand-Hammarstrom B, Akfur C, Ahlinder L, Bucht A, Osterlund L (2011) Polymorph- and size-dependent uptake and toxicity of TiO2 nanoparticles in living lung epithelial cells. Small 7:514–523
Athinarayanan J, Periasamy VS, Alsaif MA, Al-Warthan AA, Alshatwi AA (2014) Presence of nanosilica (E551) in commercial food products: TNF-mediated oxidative stress and altered cell cycle progression in human lung fibroblast cells. Cell Biol Toxicol 30:89–100
Baird WM, Hooven LA, Mahadevan B (2005) Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen 45:106–114
Barnard AS (2006) Nanohazards: knowledge is our first defence. Nat Mater 5:245
Barnes AL, Wassel RA, Mondale F, Chen K, Dormer KL, Kopke RD (2007) Magnetic characterization of superparamagnetic nanoparticles pulled through model membranes. BioMagn Res Technol 5:1
Bergin IL, Witzmann FA (2013) Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol 3(1–2)
Boogaard H, Kos GP, Weijers EP, Janssen NA, Fischer PH, van der Zee SC, de Hartog JJ, Hoek G (2011) Contrast in air pollution components between major streets and background locations: particulate matter mass, black carbon, elemental composition, nitrogen oxide and ultrafine particle number. Atmos Environ 45:650–658
Borm PJ, Cakmak G, Jermann E, Weishaupt C, Kempers P, van Schooten FJ, Oberdörster G, Schins RP (2005) Formation of PAH–DNA adducts after in vivo and vitro exposure of rats and lung cells to different commercial carbon blacks. Toxicol Appl Pharmacol 205:157–167
Bouallegui Y, Ben Younes R, Turki F, Oueslati R (2017) Impact of exposure time, particle size and uptake pathway on silver nanoparticle effects on circulating immune cells in mytilus galloprovincialis. J Immunotoxicol 14:116–124
Boverhof DR, Bramante CM, Butala JH, Clancy SF, Lafranconi M, West J, Gordon SC (2015) Comparative assessment of nanomaterial definitions and safety evaluation considerations. Regul Toxicol Pharmacol 73:137–150
Bowden LP, Royer MC, Hallman JR, Lewin-Smith M, Lupton GP (2011) Rapid onset of argyria induced by a silver-containing dietary supplement. J Cutan Pathol 38:832–835
Braakhuis HM, Cassee FR, Fokkens PH, De La Fonteyne LJ, Oomen AG, Krystek P, De Jong WH, Van Loveren H, Park MV (2016) Identification of the appropriate dose metric for pulmonary inflammation of silver nanoparticles in an inhalation toxicity study. Nanotoxicology 10:63–73
Chatterjee R (2009) Calculating the costs of nanohazard testing. ACS Publications, pp 3405–3405
Chen YS, Hung YC, Liau I, Huang GS (2009) Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett 4:858
Chen Z, Sheng X, Wang J, Wen Y (2018) Silver nanoparticles or free silver ions work? An enantioselective phytotoxicity study with a chiral tool. Sci Total Environ 610:77–83
Cho M, Cho WS, Choi M, Kim SJ, Han BS, Kim SH, Kim HO, Sheen YY, Jeong J (2009) The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 189:177–183
Choi J, Zheng Q, Katz HE, Guilarte TR (2010) Silica-based nanoparticle uptake and cellular response by primary microglia. Environ Health Perspect 118:589–595
Chulz J, Hohenberg H, Pflucker F, Gartner E, Will T, Pfeiffer S, Wepf R, Wendel V, Gers-Barlag H, Wittern KP (2002) Distribution of sunscreens on skin. Adv Drug Deliv Rev (Suppl 1):S157–163
De Domenico I, Ward DM, Kaplan J (2007) Hepcidin regulation: ironing out the details. J Clin Investig 117:1755–1758
De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3:133
Dekkers S, Bouwmeester H, Bos PM, Peters RJ, Rietveld AG, Oomen AG (2013) Knowledge gaps in risk assessment of nanosilica in food: evaluation of the dissolution and toxicity of different forms of silica. Nanotoxicology 7:367–377
Dekkers S, Oomen AG, Bleeker EA, Vandebriel RJ, Micheletti C, Cabellos J, Janer G, Fuentes N, Vázquez-Campos S, Borges T, Silva MJ (2016) Towards a nanospecific approach for risk assessment. Regul Toxicol Pharmacol 80:46–59
Delfino RJ, Staimer N, Tjoa T, Arhami M, Polidori A, Gillen DL, George SC, Shafer MM, Schauer JJ, Sioutas C (2016) Associations of primary and secondary organic aerosols with airway and systemic inflammation in an elderly panel cohort. Epidemiology (Cambridge, Mass) 21(6)
Demir E, Castranova V (2016) Genotoxic effects of synthetic amorphous silica nanoparticles in the mouse lymphoma assay. Toxicol Rep 3:807–815
Derfus AM, Chan WC, Bhatia SN (2004) Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4:11–18
Dhawan A, Sharma V (2010) Toxicity assessment of nanomaterials: methods and challenges. Anal Bioanal Chem 398:589–605
Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE (2008) Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–495
Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469
Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, Tran L, Stone V (2002) The pulmonary toxicology of ultrafine particles. J Aerosol Med 15:213–220
Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V (2005) Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Particle Fibre Toxicol 2:10
Elsaesser A, Howard CV (2012) Toxicology of nanoparticles. Adv Drug Deliv Rev 64:129–137
Exbrayat JM, Moudilou EN and Lapied E (2015) Harmful effects of nanoparticles on animals. J Nanotechnol
Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed 7:5577–5591
Gaskell G, Eyck TT, Jackson J, Veltri G (2005) Imagining nanotechnology: cultural support for technological innovation in Europe and the United States. Pub Underst Sci 14(1):81–90
Gatoo MA, Naseem S, Arfat MY, Mahmood Dar A, Qasim K, Zubair S (2014) Physicochemical properties of nanomaterials: implication in associated toxic manifestations. BioMed Res Int. http://dx.doi.org/10.1155/2014/498420
Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W (2008) The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol 38:371–376
Georgieva JV, Kalicharan D, Couraud PO, Romero IA, Weksler B, Hoekstra D, Zuhorn IS (2011) Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood–brain barrier endothelial cells in vitro. Mol Ther 19:318–325
Goulaouic S, Foucaud L, Bennasroune A, Laval-Gilly P, Falla J (2008) Effect of polycyclic aromatic hydrocarbons and carbon black particles on pro-inflammatory cytokine secretion: impact of PAH coating onto particles. J Immunotoxicol 5:337–345
Gui S, Zhang Z, Zheng L, Cui Y, Liu X, Li N, Sang X, Sun Q, Gao G, Cheng Z (2011) Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles. J Hazard Mater 195:365–370
Gwinn MR, Vallyathan V (2006) Nanoparticles: health effects—pros and cons. Environ Health Perspect 114:1818
Hillyer JF, Albrecht RM (2001) Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90:1927–1936
Hoet PH, Brüske-Hohlfeld I, Salata OV (2004) Nanoparticles-known and unknown health risks. J Nanobiotechnol 2:12
Hoshino A, Fujioka K, Oku T, Nakamura S, Suga M, Yamaguchi Y, Suzuki K, Yasuhara M, Yamamoto K (2004) Quantum dots targeted to the assigned organelle in living cells. Microbiol Immunol 48:985–994
Hsiao I, Huang Y (2011) Effects of various physicochemical characteristics on the toxicities of ZnO and TiO2 nanoparticles toward human lung epithelial cells. Sci Total Environ 409:1219–1228
Jania P, McCarthya D, Florence AT (1994) Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int J Pharm 105:157–168
Kahru A, Dubourguier HC (2010) From ecotoxicology to nanoecotoxicology. Toxicology 269:105–119
Kasaai MR (2015) Nanosized particles of silica and its derivatives for applications in various branches of food and nutrition sectors. J Nanotechnol
Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA (1995) Passage of peptides through the blood–brain barrier with colloidal polymer particles (nanoparticles). Brain Res 674:171–174
Kreyling WG, Semmler M, Möller W (2004) Dosimetry and toxicology of ultrafine particles. J Aerosol Med 17:140–152
Kuempel ED, Geraci CL, Schulte PA (2012) Risk assessment and risk management of nanomaterials in the workplace: translating research to practice. Annals Occup Hyg 56:491–505
L’Azou B, Jorly J, On D, Sellier E, Moisan F, Fleury-Feith J, Cambar J, Brochard P, Ohayon-Courtès C (2008) In vitro effects of nanoparticles on renal cells. Particle Fibre Toxicol 5:22
Lee S, Yun HS, Kim SH (2011) The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 32:9434–9443
Lin MM, Kim HH, Kim H, Dobson J, Kim DK (2010) Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy. Nanomed 5(1):109–133
Liu A, Ye B (2013) Application of gold nanoparticles in biomedical researches and diagnosis. Clin Lab 8:23–36
Liu S, Wang C, Hou J, Wang P, Miao L, Fan X, You G, Xu Y (2018) Effects of Ag and Ag2S nanoparticles on denitrification in sediments. Water Res 137:28–36
Lu X, Zhu T, Chen C, Liu Y (2014) Right or left: the role of nanoparticles in pulmonary diseases. Int J Mol Sci 15:17577–17600
Maynard A (2006) Nanotechnology: a research strategy for addressing risk. Nanotechnologies, Woodrow Wilson International Center for Scholars Project on Emerging. Washington DC
Moore MN (2006) Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? Environ Int 32:967–976
Murthy SK (2007) Nanoparticles in modern medicine: state of the art and future challenges. Int J Nanomed 2:129
Murugadoss S, Lison D, Godderis L, Van Den Brule S, Mast J, Brassinne F, Sebaihi N, Hoet PH (2017) Toxicology of silica nanoparticles: an update. Arch Toxicol 91:2967–3010
Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–627
Nowack B, Bucheli TD (2007) Occurrence, behavior and effects of nanoparticles in the environment. Environ Pollut 150:5–22
Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823
Pan D, Vargas-Morales O, Zern B, Anselmo AC, Gupta V, Zakrewsky M, Mitragotri S, Muzykantov V (2016) The effect of polymeric nanoparticles on biocompatibility of carrier red blood cells. PLoS ONE 11(3):e0152074
Park EJ, Park K (2009) Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett 184:18–25
Park EJ, Bae E, Yi J, Kim Y, Choi K, Lee SH, Yoon J, Lee BC, Park K (2010) Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 30(2):162–168
Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, MacNee W, Donaldson K (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423
Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, Young AN, Wang MD, Nie S (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 26:83
Schmid O, Stoeger T (2016) Surface area is the biologically most effective dose metric for acute nanoparticle toxicity in the lung. J Aerosol Sci 99:133–143
Schulte PA, Geraci CL, Hodson LL, Zumwalde RD, Kuempel ED, Murashov V, Martinez KF, Heidel DS (2013) Overview of risk management for engineered nanomaterials. J Phys Conf Ser 429
Schuppan D, Schattenberg JM (2013) Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol 28:68–76
Scott-Fordsmand JJ, Peignenburg WJGM, Semenzin E, Novack B, Hunt N, Hristozov D, Marcomini A, Irfan M-A, Jimenez AS, Landsiedel R, Tran L, Oomen AG, Bos PMJ, Hund-Rinke K (2017) Environmental risk assessment strategy for nanomaterials. Int J Environ Res Public Health 14:1251
Seaton A, Tran L, Aitken R, Donaldson K (2009) Nanoparticles, human health hazard and regulation. J Roy Soc Interface 7(Suppl 1):S119–S129
Senzui M, Tamura T, Miura K, Ikarashi Y, Watanabe Y, Fujii M (2010) Study on penetration of titanium dioxide (TiO(2)) nanoparticles into intact and damaged skin in vitro. J Toxicol Sci 35:107–113
Sharma M (2010) Understanding the mechanism of toxicity of carbon nanoparticles in humans in the new millennium: a systemic review. Indian J Occup Environ Med 14(1):3–5
Shimida A, Kawamura N, Okajima M, Kaewamatawong T, Inoue H, Morita T (2006) Translocation pathway of the intratracheally instilled ultrafine particles from the lung into blood circulation in the mouse. Toxicol Pathol 34:949–957
Subbenaik SC (2016) Physical and chemical nature of nanoparticles. In: Plant nanotechnology. Springer, Cham, pp 15–27
Tinkle SS, Antonini JM, Rich BA, Robert JR, Salmen R, DePree K, Adkins EJ (2003) Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111:1202–1208
Truong L, Saili KS, Miller JM, Hutchison JE, Tanguay RL (2012) Persistent adult zebrafish behavioral deficits results from acute embryonic exposure to gold nanoparticles. Comp Biochem Physiol C: Toxicol Pharmacol 8:269–274
Tsuji JS, Maynard AD, Howard PC, James JT, Lam C-W, Warheit DB, Santmaria AB (2005) Research strategies for safety evaluation of nanomaterials, Part IV: Risk assessment of nanoparticles. Toxicol Sci 89:42–50
Vance ME, Kuiken T, Vejerano EP, McGinnis SP, Hochella MF Jr, Rejeski D, Hull MS (2015) Nanotechnology in the real world: redeveloping the nanomaterial consumer products inventory. Beilstein J Nanotechnol 6:1769
Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, Jia G, Gao Y, Li B, Sun J (2007a) Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168:176–185
Wang JJ, Sanderson BJ, Wang H (2007b) Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutat Res 628:99–106
Wang X, Ding B, Li B (2013) Biomimetic electrospun nanofibrous structures for tissue engineering. Mater Today 16:229–241
Xia Y, Yu H, Jansen R, Seringhaus M, Baxter S, Greenbaum D, Zhao H, Gerstein M (2004) Analyzing cellular biochemistry in terms of molecular networks. Annu Rev Biochem 73:1051–1087
Yin H, Too HP, Chow GM (2005) The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 26:5818–5826
Zhang WL, Yu WW, Vicki LC, Monteiro-Riviere NA (2008) Biological interactions of quantum dot NPs in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol 228:200–211
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jamil, B., Javed, R., Qazi, A.S., Syed, M.A. (2018). Nanomaterials: Toxicity, Risk Managment and Public Perception. In: Rai, M., Biswas, J. (eds) Nanomaterials: Ecotoxicity, Safety, and Public Perception. Springer, Cham. https://doi.org/10.1007/978-3-030-05144-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-05144-0_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-05143-3
Online ISBN: 978-3-030-05144-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)